trimmed of atria and large vessels and cut in 2 to 3 mm pieces for repeated incubation (5) (6) times @ 37°C for 25 minutes) in buffer containing collagenase type II (95 U/mL; Worthington) and pancreatin (0.6 mg/mL; Gibco BRL). After each incubation the supernatant was collected and centrifuged (600g, 5 minutes), then the resulting cell pellet was resuspended in DMEM/M199 (4:1) supplemented with 10% horse serum (ICN Flow), 5% fetal bovine serum (HyClone), penicillin G (100 U/mL) and streptomycin (100 µg/mL) (Gibco) and preplated for 30 minutes to reduce contaminating nonmyocytes. Cardiomyocytes were pooled and counted with a typical cell yield of 1x10 6 per neonatal heart. The cells were then plated in media onto sterile, gel-coated 6-well dishes at a concentration of 2x10 5 sarcomere length is noted in Table 1 Table 3 ) and demonstrate that the rate and extent of shortening was increased in all groups as compared to 22-24°C, but that contractile potentiation is maintained in Rrm1+Rrm2 transduced myocytes over non-transduced and GFP transduced myocytes. Similarly, the rates of Ca 2+ release and re-uptake were also increased at Figure 2 , and measurements are summarized in Supplemental Table 4 .
Statistical Analysis. Maximal cardiomyocyte shortening and relengthening and calcium transient rise and decay were calculated offline using IonOptix software to determine the maximum of the first derivative of these transients. Times to peak shortening and 50% and 90% return to baseline were also calculated offline. To convert the fluorescence data to [Ca 2+ ] i an in vitro calibration of the measured ratio (R) was performed using the Grynkiewicz equation . Data reflect the averages of individual cardiomyocytes taken from 5 hearts per group. All observed differences were maintained even when averaged on a heart-by-heart basis, as compared to the cell-by-cell basis as reports. This is demonstrated in Supplemental Table 6 , where "by heart" averages are compared to "by cell" averages as reported in Table 2 of the main manuscript. nm and emission monitored through a KV 398 nm cutoff filter as described previously 7 . The stopped-flow transients were fitted to one or two exponentials by non-linear least squares curve fitting using the Kinetic Studio software (TgK Scientific). All experiments were carried out in 20 mM Cacodylate buffer, pH 7.0 containing 100 mM KCl, and 5 mM MgCl 2 . Rabbit skeletal muscle actin was purified as previously described 8 . Skeletal muscle myosin S1 was prepared from rabbit bulk muscle (fast), rabbit soleus and mouse heart based on Margossian and Lowey 9 and
Weeds and Taylor 10 with some modifications 7 .
The results of the kinetic interaction of actin -S1 with nucleotide were interpreted in terms of the model in Scheme 1, which we described previously for fast and slow skeletal muscle myosin 7 . This is based on the scheme originally proposed by Geeves, Perrault and Coluccio 11 for non-muscle myosin class I.
In the scheme, the equilibrium constants are defined in the direction from AM" towards MT, thus K 1 is an association constant. A very rapid equilibrium is reached between AM and ATP after mixing actin-S1 with ATP, defined by the association constant K 1 and followed by isomerization of the ternary complex (AMT), which limits the maximum rate of actin R1R2 (GFP) 10.7 ± 0.9* † 126.8 ± 9.2* † 178 ± 13 150.2 ± 4.2* † 110 ± 12* 209 ± 22* † 1.14 ± 0.03 1.27 ± 0.03 103 ± 9* † 262 ± 20* † dissociation from the complex (k +2 ). Thus, the observed rate constant for the ATP-induced actin-S1 dissociation is defined by the equation 1:
For some myosins i k(like slow skeletal myosin), an additional slow time course component is seen with a rate constant defined by k + and the relative amplitudes of the fast and slow phases defined by the equation 2 :
For fast skeletal myosin, if the closed form exists, the term K  >> 1 and only a single phase is observed. There were no differences observed at either temperature between ATP and dATP for a given myosin isoform. 
Supplemental

